Small Animal Imaging (In-Vivo) - Global Strategic Business Report

Report
194 Pages
April 2024
Region: Global
Global Industry Analysts, Inc
ID: 5140277

Global Small Animal Imaging (In-Vivo) Market to Reach $4.3 Billion by 2030

The global market for Small Animal Imaging (In-Vivo) estimated at US$2.6 Billion in the year 2023, is projected to reach a revised size of US$4.3 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Micro-Magnetic Resonance Imaging Modality, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$1 Billion by the end of the analysis period. Growth in the Optical Imaging Modality segment is estimated at 7.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $793.7 Million, While China is Forecast to Grow at 7% CAGR

The Small Animal Imaging (In-Vivo) market in the U.S. is estimated at US$793.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$735.2 Million by the year 2030 trailing a CAGR of 7% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.2% and 6.2% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Report Features

Full access to influencer engagement stats
Free access to digital archives & research platform. The proprietary platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. The state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
Complimentary report updates for one year
Competitor coverage with global market shares of major players
Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 42 Featured):

Aspect Imaging Ltd.
Berthold Technologies GmbH & Co. KG
Bruker Corp.
LI-COR Biosciences, Inc.
Mediso Ltd.
MILabs B.V.
Miltenyi Biotec GmbH
New England Biolabs, Inc.
Northridge Tri-Modality Imaging, Inc.
PerkinElmer, Inc.
Scanco Medical AG
Sofie Biosciences, Inc.
Thermo Fisher Scientific Inc.
Uvp. LLC

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Global Economic Update
Small Animal Imaging (In-Vivo) - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 2: World Historic Review for Small Animal Imaging (In-Vivo) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 3: World 16-Year Perspective for Small Animal Imaging (In-Vivo) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
Table 4: World Recent Past, Current & Future Analysis for Micro-magnetic resonance imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 5: World Historic Review for Micro-magnetic resonance imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 6: World 16-Year Perspective for Micro-magnetic resonance imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 7: World Recent Past, Current & Future Analysis for Optical imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 8: World Historic Review for Optical imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 9: World 16-Year Perspective for Optical imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 10: World Recent Past, Current & Future Analysis for Nuclear imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 11: World Historic Review for Nuclear imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 12: World 16-Year Perspective for Nuclear imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 13: World Recent Past, Current & Future Analysis for Other Imaging Modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 14: World Historic Review for Other Imaging Modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 15: World 16-Year Perspective for Other Imaging Modalities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 16: World Recent Past, Current & Future Analysis for Monitoring treatment response by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 17: World Historic Review for Monitoring treatment response by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 18: World 16-Year Perspective for Monitoring treatment response by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 19: World Recent Past, Current & Future Analysis for Bio-distribution of drug by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 20: World Historic Review for Bio-distribution of drug by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 21: World 16-Year Perspective for Bio-distribution of drug by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 22: World Recent Past, Current & Future Analysis for Cancer cell detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 23: World Historic Review for Cancer cell detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 24: World 16-Year Perspective for Cancer cell detection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 25: World Recent Past, Current & Future Analysis for Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 26: World Historic Review for Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 27: World 16-Year Perspective for Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 28: World Recent Past, Current & Future Analysis for Longitudinal studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 29: World Historic Review for Longitudinal studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 30: World 16-Year Perspective for Longitudinal studies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 31: World Recent Past, Current & Future Analysis for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 32: World Historic Review for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 33: World 16-Year Perspective for Epigenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 34: World Small Animal Imaging (In-Vivo) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES

Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
Table 35: USA Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 36: USA Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 37: USA 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
Table 38: USA Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 39: USA Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 40: USA 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030

CANADA

Table 41: Canada Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 42: Canada Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 43: Canada 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
Table 44: Canada Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 45: Canada Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 46: Canada 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030

JAPAN

Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
Table 47: Japan Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 48: Japan Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 49: Japan 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
Table 50: Japan Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 51: Japan Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 52: Japan 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030

CHINA

Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
Table 53: China Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 54: China Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 55: China 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
Table 56: China Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 57: China Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 58: China 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030

EUROPE

Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
Table 59: Europe Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 60: Europe Historic Review for Small Animal Imaging (In-Vivo) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 61: Europe 16-Year Perspective for Small Animal Imaging (In-Vivo) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
Table 62: Europe Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 63: Europe Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 64: Europe 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
Table 65: Europe Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 66: Europe Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 67: Europe 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030

FRANCE

Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
Table 68: France Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 69: France Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 70: France 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
Table 71: France Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 72: France Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 73: France 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030

GERMANY

Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
Table 74: Germany Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 75: Germany Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 76: Germany 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
Table 77: Germany Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 78: Germany Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 79: Germany 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030

ITALY

Table 80: Italy Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 81: Italy Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 82: Italy 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
Table 83: Italy Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 84: Italy Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 85: Italy 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030

UNITED KINGDOM

Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
Table 86: UK Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 87: UK Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 88: UK 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
Table 89: UK Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 90: UK Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 91: UK 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030

REST OF EUROPE

Table 92: Rest of Europe Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 93: Rest of Europe Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 94: Rest of Europe 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
Table 95: Rest of Europe Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 96: Rest of Europe Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 97: Rest of Europe 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030

ASIA-PACIFIC

Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 99: Asia-Pacific Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 100: Asia-Pacific 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 102: Asia-Pacific Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 103: Asia-Pacific 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030

REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Aspect Imaging Ltd.
Berthold Technologies GmbH & Co. KG
Bruker Corp.
LI-COR Biosciences, Inc.
Mediso Ltd.
MILabs B.V.
Miltenyi Biotec GmbH
New England Biolabs, Inc.
Northridge Tri-Modality Imaging, Inc.
PerkinElmer, Inc.
Scanco Medical AG
Sofie Biosciences, Inc.
Thermo Fisher Scientific Inc.
Uvp. LLC

Table Information

Report Attribute	Details
No. of Pages	194
Published	April 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 2.6 Billion
Forecasted Market Value ( USD ) by 2030	$ 4.3 Billion
Compound Annual Growth Rate	7.7%
Regions Covered	Global

PURCHASE OPTIONS

Single User License PDF

1 - 10 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4778EUR$4,950USD£4,098GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€9078EUR$9,405USD£7,787GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€14333EUR$14,850USD£12,295GBP

Global Small Animal Imaging (In-Vivo) Market to Reach $4.3 Billion by 2030

The U.S. Market is Estimated at $793.7 Million, While China is Forecast to Grow at 7% CAGR

Report Features

What to Expect from the Global Economy in 2024

Select Competitors (Total 42 Featured):

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

Small Animal Imaging (In-Vivo) Global Market Report 2024

Global Small Animal Imaging Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Small Animal Imaging Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

Global Small Animal Imaging Market by Technology (Micro Magnetic Resonance Imaging, Nuclear Imaging, Optical Imaging), Application (Cancer Cell Detection, Epigenetics, Longitudinal Studies) - Forecast 2024-2030

Small Animal Imaging Reagent Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type